Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2025-10-13 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Avacta to present data at EORTC-NCI-AACR
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces that Avacta Group PLC will present scientific data at an upcoming medical conference (2025 EORTC-NCI-AACR). It does not contain the actual research report or financial results, but rather serves as a corporate announcement regarding future presentation activities. As it is a general regulatory announcement that does not fit into specific categories like earnings or dividends, it is classified as a Regulatory Filing (RNS).
2025-10-13 English
Interim Half Year Results 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Results for the six months to June 30, 2025' and contains comprehensive financial data, including a 'Financial Review' section, revenue figures, operating losses, and cash flow analysis for the interim period. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-30 English
Notice of Interim Results
Report Publication Announcement Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from Avacta Group PLC. It serves as a notification regarding the upcoming release of interim results and an investor presentation, as well as an update on a conference presentation. Per the 'Menu vs Meal' rule, this is an announcement about a report (RPA) rather than the report itself, as it provides the date for the future release of the interim results.
2025-09-15 English
Shortlisted for AIM Awards Technology of the Year
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the RNS Reach service regarding a company award nomination (shortlisting for the AIM Technology of the Year Award). It does not contain financial results, governance reports, or other specific regulatory filings. As it is a general corporate announcement that does not fit into the specific categories provided, it falls under the fallback category of Regulatory Filings (RNS).
2025-09-09 English
Avacta completes sale of Coris Bioconcept
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Avacta Group PLC regarding the completion of the sale of a subsidiary (Coris Bioconcept SRL). This is a corporate transaction announcement involving the divestiture of assets. While it relates to M&A activity, the 'TAR' category is specifically for merger proposals or takeover bids. Since this is a completed divestiture announcement, it fits best under 'RNS' (Regulatory Filings) as a general corporate announcement, or potentially 'TAR' if interpreted broadly. Given the specific nature of the transaction, 'TAR' is the most accurate classification for M&A-related activity.
2025-09-01 English
Amendments to Convertible Bond + equity fundraise
Regulatory Filings Classification · 98% confidence The document is an official announcement from Avacta Group PLC regarding a capital raise of £3.25 million through a share placing and amendments to an existing convertible bond. It details the terms of the placing, the use of proceeds, and the conditions of the bond amendment. This falls under the category of capital structure changes and financing activities. It is not a report publication announcement (RPA) as it contains the substantive details of the transaction itself, nor is it a share issue (SHA) in the context of a simple corporate action, as it is primarily a financing/capital update.
2025-08-29 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.